$ADTX
Aditxt, Inc. Stock $adtx

$adtx Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022048035 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$323.1K	$214.7K	$210.3K
YoY Change
Cost Of Revenue	$233.7K	$174.9K	$188.1K
YoY Change
Gross Profit	$89.44K	$39.86K	$22.21K
YoY Change
Gross Profit Margin	27.68%	18.56%	10.56%
Selling, General & Admin	$3.911M	$833.9K	$4.711M
YoY Change	-15.01%	1797.78%	-8.71%
% of Gross Profit	4372.79%	2092.34%	21210.09%
Research & Development	$1.571M	$1.188M	$1.428M
YoY Change	6.73%	27.36%	51.96%
% of Gross Profit	1755.95%	2980.46%	6431.25%
Depreciation & Amortization	$126.7K	$99.85K	$123.6K
YoY Change	-0.07%	-0.43%	23.6%
% of Gross Profit	141.7%	250.53%	556.51%
Operating Expenses	$5.482M	$2.022M	$6.139M
YoY Change	-9.74%	107.01%	0.81%
Operating Profit	-$5.392M	-$5.771M	-$6.117M
YoY Change	-11.21%	-0.07%	0.44%
Interest Expense	-$2.165M	-$79.05K
YoY Change	82.49%	-80.41%
% of Operating Profit
Other Income/Expense, Net	-$2.165M	-$79.05K	$58.96K
YoY Change	-41.28%	-80.41%
Pretax Income	-$7.558M	-$5.850M	-$6.059M
YoY Change	-22.57%	-5.32%	-5.03%
Income Tax
% Of Pretax Income
Net Earnings	-$7.558M	-$5.850M	-$6.059M
YoY Change	-22.57%	-5.32%	-5.02%
Net Earnings / Revenue	-2338.9%	-2724.54%	-2881.46%
Basic Earnings Per Share	-$5.27	-$0.13	-$6.80
Diluted Earnings Per Share	-$5.27	-$0.13	-$135.9K
COMMON SHARES
Basic Shares Outstanding	56.85M shares	45.56M shares	891.6K shares
Diluted Shares Outstanding	1.433M shares	45.56M shares	891.6K shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.245M	$804.0K	$2.115M
YoY Change	69.03%	-90.66%	-84.95%
Cash & Equivalents	$9.245M	$804.0K	$2.115M
Short-Term Investments
Other Short-Term Assets	$689.4K	$590.4K	$534.9K
YoY Change	65.7%	-55.15%	-29.61%
Inventory	$1.442M	$1.333M	$1.042M
Prepaid Expenses	$689.4K	$590.4K
Receivables	$662.8K	$410.6K	$248.8K
Other Receivables	$585.4K	$500.0K	$500.0K
Total Short-Term Assets	$12.62M	$3.638M	$4.441M
YoY Change	1.93%	-63.35%	-70.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.249M	$2.345M	$6.202M
YoY Change	-63.86%	-56.39%	118.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$398.1K	$410.8K	$446.8K
YoY Change	26.12%	51.14%	538.34%
Other Assets	$347.6K	$524.5K	$515.1K
YoY Change	-17.66%	740.76%
Total Long-Term Assets	$6.555M	$7.102M	$7.351M
YoY Change	-8.97%	18.79%	129.01%
TOTAL ASSETS
Total Short-Term Assets	$12.62M	$3.638M	$4.441M
Total Long-Term Assets	$6.555M	$7.102M	$7.351M
Total Assets	$19.18M	$10.74M	$11.79M
YoY Change	-2.08%	-32.48%	-34.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.712M	$4.813M	$2.559M
YoY Change	63.77%	297.13%	163.83%
Accrued Expenses	$1.123M	$1.131M	$1.138M
YoY Change	10.13%	24.7%	191.79%
Deferred Revenue
YoY Change
Short-Term Debt	$80.00K	$465.9K	$0.00
YoY Change
Long-Term Debt Due	$246.7K	$438.4K	$626.3K
YoY Change	-66.85%	-85.32%	-52.19%
Total Short-Term Liabilities	$4.373M	$7.041M	$4.515M
YoY Change	21.45%	34.68%	32.78%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$2.112M	$2.338M	$2.555M
YoY Change	-23.65%	-20.98%	87.84%
Total Long-Term Liabilities	$2.112M	$2.338M	$2.555M
YoY Change	-29.9%	-50.4%	-21.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.373M	$7.041M	$4.515M
Total Long-Term Liabilities	$2.112M	$2.338M	$2.555M
Total Liabilities	$6.485M	$9.379M	$7.069M
YoY Change	-1.95%	-5.66%	6.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$86.83M	-$79.26M
YoY Change
Common Stock	$3.731K	$55.47K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$201.6K	$201.6K
YoY Change
Treasury Stock Shares	2.017K shares	100.8K shares
Shareholders Equity	$12.69M	$1.361M	$4.723M
YoY Change
Total Liabilities & Shareholders Equity	$19.18M	$10.74M	$11.79M
YoY Change	-2.08%	-32.48%	-34.56%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$7.558M	-$5.850M	-$6.059M
YoY Change	-22.57%	-5.32%	-5.02%
Depreciation, Depletion And Amortization	$126.7K	$99.85K	$123.6K
YoY Change	-0.07%	-0.43%	23.6%
Cash From Operating Activities	-$7.818M	-$2.654M	-$5.199M
YoY Change	72.75%	-47.03%	28.38%
INVESTING ACTIVITIES
Capital Expenditures	-$4.190K	-$126.3K	-$147.8K
YoY Change	-97.7%	-44.72%	-69.84%
Acquisitions
YoY Change
Other Investing Activities	$91.62K	-$9.440K	-$225.6K
YoY Change	-101.34%	-84.87%
Cash From Investing Activities	$87.44K	-$135.7K	-$373.4K
YoY Change	-101.24%	-53.34%	-23.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	16.17M	1.479M	-184.2K
YoY Change	91.9%	-1246.79%	-102.28%
NET CHANGE
Cash From Operating Activities	-7.818M	-2.654M	-5.199M
Cash From Investing Activities	87.44K	-135.7K	-373.4K
Cash From Financing Activities	16.17M	1.479M	-184.2K
Net Change In Cash	8.441M	-1.311M	-5.757M
YoY Change	-368.76%	-75.86%	-262.62%
FREE CASH FLOW
Cash From Operating Activities	-$7.818M	-$2.654M	-$5.199M
Capital Expenditures	-$4.190K	-$126.3K	-$147.8K
Free Cash Flow	-$7.814M	-$2.528M	-$5.052M
YoY Change	79.9%	-47.14%	41.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39336
	dei	Entity Registrant Name EntityRegistrantName	Aditxt, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3204328
	dei	Entity Address Address Line1 EntityAddressAddressLine1	737 N. Fifth Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Richmond
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	23219
	dei	City Area Code CityAreaCode	(650)
	dei	Local Phone Number LocalPhoneNumber	870-1200
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	ADTX
CY2022Q2	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	192984	usd
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	186058	usd
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	adtx	Financing On Fixed Assets FinancingOnFixedAssets	700433	usd
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56846331	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	803971	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7872061	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	410593	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89844	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	590418	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	460102	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	500000	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	500000	usd
CY2022Q2	us-gaap	Public Utilities Inventory PublicUtilitiesInventory	1332895	usd
CY2021Q4	us-gaap	Public Utilities Inventory PublicUtilitiesInventory	494697	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	3637877	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9416704	usd
CY2022Q2	adtx	Fixed Asset FixedAsset	2344666	usd
CY2021Q4	adtx	Fixed Asset FixedAsset	2267297	usd
CY2022Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	160500	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	214000	usd
CY2022Q2	adtx	Right Of Use Asset Long Term RightOfUseAssetLongTerm	3661247	usd
CY2021Q4	adtx	Right Of Use Asset Long Term RightOfUseAssetLongTerm	4097117	usd
CY2022Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	410837	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	379250	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	524548	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	289539	usd
CY2022Q2	us-gaap	Assets Assets	10739675	usd
CY2021Q4	us-gaap	Assets Assets	16663907	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4813224	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1575543	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	465848	usd
CY2022Q2	adtx	Financing On Fixed Assets FinancingOnFixedAssets	438398	usd
CY2022Q2	adtx	Operating Lease Liability Short Term Current OperatingLeaseLiabilityShortTermCurrent	1130611	usd
CY2021Q4	adtx	Operating Lease Liability Short Term Current OperatingLeaseLiabilityShortTermCurrent	1145126	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7041065	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3607160	usd
CY2021Q4	adtx	Financing Of Fixed Asset Long Term FinancingOfFixedAssetLongTerm	110041	usd
CY2022Q2	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	2337652	usd
CY2021Q4	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	2765933	usd
CY2022Q2	us-gaap	Liabilities Liabilities	9378717	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6483134	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55469356	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44530486	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55368553	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44429683	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	55473	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	44534	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	100803	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	100803	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	80769046	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	77690653	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79261956	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67352809	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1360958	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10739675	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16663907	usd
CY2022Q2	us-gaap	Revenues Revenues	214715	usd
	us-gaap	Revenues Revenues	424994	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	174858	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	362929	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	39857	usd
	us-gaap	Gross Profit GrossProfit	62065	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3788952	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4798313	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8413110	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9896830	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1187920	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	932751	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2616302	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1868703	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	833942	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	43943	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	920541	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	102506	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5810814	usd
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5775007	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11949953	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	11868039	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5770957	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45560639	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14563699	shares
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5775007	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11887888	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45073383	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14198485	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11868039	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	82110	usd
CY2021Q2	us-gaap	Interest Expense Other InterestExpenseOther	19586	usd
	us-gaap	Interest Expense Other InterestExpenseOther	97320	usd
	us-gaap	Interest Expense Other InterestExpenseOther	36389	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	6007	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	180	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	20047	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	429	usd
	us-gaap	Other Income OtherIncome	58960	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2946	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	384023	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2946	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	654104	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79049	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-403429	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21259	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-690064	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5850006	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6178436	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11909147	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12558103	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5850006	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6178436	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11909147	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12558103	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022Q1	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	219885	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	377671	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3719	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6059141	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4722907	usd
CY2022Q2	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	724584	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	309704	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1203769	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	250000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5850006	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1360958	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11011482	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	718425	usd
	adtx	Ti Allowance Receivable TIAllowanceReceivable	215173	usd
CY2021Q1	adtx	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	3718956	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	51240	usd
CY2021Q1	adtx	Stock Issued During Period Value Issuance Of Shares For Compensation StockIssuedDuringPeriodValueIssuanceOfSharesForCompensation	1112200	usd
CY2021Q1	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	301462	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1322840	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	231316	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6379667	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	11369829	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	181860	usd
CY2021Q2	adtx	Stock Issued During Period Value Issuance Of Shares For Compensation StockIssuedDuringPeriodValueIssuanceOfSharesForCompensation	331500	usd
CY2021Q2	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	259070	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6178436	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5963823	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11909147	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12558103	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1885563	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2237332	usd
	us-gaap	Depreciation Depreciation	196704	usd
	us-gaap	Depreciation Depreciation	166529	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53500	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53060	usd
	adtx	Amortization Of Debt Discount AmortizationOfDebtDiscount	2946	usd
	adtx	Amortization Of Debt Discount AmortizationOfDebtDiscount	654104	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	320749	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	130316	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	199536	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	838198	usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	31587	usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	384707	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3237681	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	970384	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7853603	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9060937	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	274073	usd
	adtx	Ti Allowance Receivable TIAllowanceReceivable	62393	usd
	adtx	Note Receivables And Accrued Interest NoteReceivablesAndAccruedInterest	19836	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-509082	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-780818	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	550000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5000000	usd
	adtx	Discount On Convertible Note Payable From Offering Costs DiscountOnConvertibleNotePayableFromOfferingCosts	-16500	usd
	adtx	Discount On Convertible Note Payable From Offering Costs DiscountOnConvertibleNotePayableFromOfferingCosts	-526460	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	70598	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3718956	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1203769	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	372076	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	241442	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1294595	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7951054	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7068090	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1890701	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7872061	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10500826	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	803971	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8610125	usd
	us-gaap	Interest Expense InterestExpense	70831	usd
	adtx	Lease Liability Recognized From Right Of Use Assets LeaseLiabilityRecognizedFromRightOfUseAssets	2806427	usd
	adtx	Original Issuance Discount On Notes Payable OriginalIssuanceDiscountOnNotesPayable	1000000	usd
	adtx	Debt Discount From Warrants Issued With Convertible Note Payable DebtDiscountFromWarrantsIssuedWithConvertibleNotePayable	1322840	usd
	adtx	Debt Discount From Warrant Consideration For Convertible Debt Offering Costs DebtDiscountFromWarrantConsiderationForConvertibleDebtOfferingCosts	231316	usd
	adtx	Liability Recognized For Financed Assets LiabilityRecognizedForFinancedAssets	821862	usd
CY2021Q3	us-gaap	Common Unit Issued CommonUnitIssued	4583334	shares
CY2021Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	2.4
CY2021Q3	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	11000000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	4583334	shares
CY2021Q3	adtx	Debt Instrument Term Description DebtInstrumentTermDescription	The warrants have an exercise price of $2.53 per share and are exercisable for a five-year period commencing six months from the date of issuance.
CY2021Q3	adtx	Warrants Exercise Price WarrantsExercisePrice	1.5
CY2021Q3	adtx	Purchase Of Common Stock PurchaseOfCommonStock	229166	shares
CY2021Q3	adtx	Exercise Price Per Shares ExercisePricePerShares	3
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	2833333	shares
CY2021Q4	adtx	Exercise Price Per Shares ExercisePricePerShares	1.5
CY2021Q4	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	4250000	usd
CY2021Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	3910000	usd
CY2021Q4	adtx	Net Proceeds NetProceeds	16000000	usd
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	8246430	shares
CY2021Q4	adtx	Prefunded Warrants Shares PrefundedWarrantsShares	8328570	shares
CY2021Q4	adtx	Exercise Price Per Shares ExercisePricePerShares	1.15
	adtx	Net Loss Cash Flow From Operating Activities NetLossCashFlowFromOperatingActivities	11909147	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7853603	usd
CY2022Q2	us-gaap	Cash Cash	803971	usd
CY2022Q2	us-gaap	Customer Funds CustomerFunds	67300000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	75000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Significant estimates underlying the condensed financial statements include the collectability of notes receivable, collectability and reserve on accounts receivable, the reserve on insurance billing, and the fair value of stock options and warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentrations of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may have deposits in excess of federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	50808	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
	adtx	Licensing Fee For Patents LicensingFeeForPatents	248813	usd
	adtx	Licensing Fee For Patents LicensingFeeForPatents	76245	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2616302	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1868703	usd
	adtx	Warrants Of Stock Options WarrantsOfStockOptions	2235466	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	865900	shares
	adtx	Dilutive Earning Shares DilutiveEarningShares	45963691	shares
	adtx	Warrants Of Stock Options WarrantsOfStockOptions	2143000	shares
	adtx	Dilutive Earning Shares DilutiveEarningShares	5463715	shares
CY2021Q3	us-gaap	Other Loans Payable OtherLoansPayable	6500000	usd
CY2021Q3	adtx	Common Stock Yields Percentage CommonStockYieldsPercentage	0.50	pure
CY2021Q4	adtx	Description Of Share Exchange Agreement DescriptionOfShareExchangeAgreement	On December 28, 2021, we entered into a Share Exchange Agreement with Cellvera Global f/k/a AiPharma Global, pursuant to which we (i) will acquire 9.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 4,816,193 shares of our common stock of Aditxt and a cash payment of $250,000, at an initial closing upon the satisfaction or waiver of certain conditions to closing; and (ii) acquire the remaining 90.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 39,927,974 shares of our common stock and a cash payment of $250,000 at a secondary closing upon the satisfaction or waiver of certain conditions to closing.
CY2021Q3	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	6500000	usd
CY2021Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2021Q4	adtx	Credit Agreement Amendment Description CreditAgreementAmendmentDescription	the Company entered into the first amendment to the Credit Agreement with Cellvera Global and certain affiliated entities (the “Credit Agreement Amendment”), pursuant to which the Company agreed to increase the amount which Cellvera Global was permitted to borrow under the Credit Agreement by $8.5 million to an aggregate of $15.0 million, of which $6.5 million was outstanding prior to entering the Credit Agreement Amendment. The Company agreed to fund such additional borrowings, as requested by Cellvera Global, by advancing 70% of any amounts received by the Company from the exercise of existing warrants or any other capital raises, including the October Offering.
CY2021	adtx	Advanced Credit Agreement AdvancedCreditAgreement	8000000	usd
CY2021	adtx	Credit Agreement CreditAgreement	14500000	usd
CY2021Q4	us-gaap	Loans Receivable With Variable Rates Of Interest1 LoansReceivableWithVariableRatesOfInterest1	14500000	usd
CY2022Q1	us-gaap	Loans Payable LoansPayable	14500000	usd
CY2022Q2	adtx	Aggregate Amounts AggregateAmounts	30000000	usd
CY2021	adtx	Credit Agreement Description CreditAgreementDescription	On December 10, 2021, the Company entered into a secured credit agreement dated December 10, 2021 (the “Target Company Credit Agreement”) and signed on December 10, 2021 with the Target Company, pursuant to which the Company made a secured loan to the Target Company in the principal amount of $500,000 (the “Target Company Loan”) and agreed to make additional secured loans, as requested by the Target Company and approved by the Company, in an amount not to exceed $4.5 million. The Target Company Loan bears interest at a rate of 8% per annum and mature on December 8, 2022, provided, that the Letter of Intent currently contemplates that the Target Company Loan will be forgivable upon the closing of the acquisition contemplated by the letter of intent. The Target Company Credit Agreement also contains certain covenants that prohibit the Target Company from incurring additional indebtedness, entering into any fundamental transactions, issuing any equity interests subject to certain limited exceptions, or making any dispositions of its property. In connection with the Target Company Credit Agreement, the Company entered into a Security Agreement with the Target Company, pursuant to which the Target Company granted the Company a security interest in all of the Target Company’s assets as security for the Target Company Loan.
CY2022Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	500000	usd
CY2022Q2	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	22356	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2928378	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	583712	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2344666	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2654307	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	387010	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2267297	usd
CY2022Q2	us-gaap	Depreciation Depreciation	99852	usd
CY2021Q2	us-gaap	Depreciation Depreciation	100286	usd
	us-gaap	Depreciation Depreciation	196704	usd
	us-gaap	Depreciation Depreciation	166529	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26750	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26676	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53500	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53060	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	480000	shares
CY2022Q2	adtx	Aggregates Amount AggregatesAmount	792000	usd
CY2022Q2	adtx	Gross Proceeds GrossProceeds	550000	usd
CY2022Q2	us-gaap	Fee Income On Acceptances Executed FeeIncomeOnAcceptancesExecuted	16500	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	13500	usd
CY2022Q2	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	465848	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	141429	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	653408	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	259293	usd
	us-gaap	Lease Cost LeaseCost	653408	usd
	us-gaap	Lease Cost LeaseCost	259293	usd
CY2022Q2	adtx	Right Of Use Assets Long Term RightOfUseAssetsLongTerm	3661247	usd
CY2021Q4	adtx	Right Of Use Assets Long Term RightOfUseAssetsLongTerm	4097117	usd
	adtx	Total Right Of Use Asset TotalRightOfUseAsset	3661247	usd
CY2021	adtx	Total Right Of Use Asset TotalRightOfUseAsset	4097117	usd
CY2022Q2	adtx	Operating Lease Liabilities Short Term OperatingLeaseLiabilitiesShortTerm	1130611	usd
CY2021Q4	adtx	Operating Lease Liabilities Short Term OperatingLeaseLiabilitiesShortTerm	1145126	usd
CY2022Q2	adtx	Operating Lease Liabilities Long Term OperatingLeaseLiabilitiesLongTerm	2337652	usd
CY2021Q4	adtx	Operating Lease Liabilities Long Term OperatingLeaseLiabilitiesLongTerm	2765933	usd
CY2022Q2	adtx	Total Lease Liability TotalLeaseLiability	3468263	usd
CY2021Q4	adtx	Total Lease Liability TotalLeaseLiability	3911059	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	adtx	Stock Based Compensation For Consulting Services StockBasedCompensationForConsultingServices	253719	usd
	adtx	Stock Based Compensation StockBasedCompensation	687375	usd
	adtx	Stock Based Compensation For Consulting Services StockBasedCompensationForConsultingServices	233100	usd
CY2021Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1163556	shares
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3718956	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	465000	shares
	adtx	Stock Based Compensation StockBasedCompensation	1443700	usd
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	3000000	shares
CY2021Q1	adtx	Fair Market Value FairMarketValue	1	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	387246	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	267318	usd
	adtx	Other Research And Development OtherResearchAndDevelopment	119928	usd
	adtx	Share Based Payment Remnaining Expenses ShareBasedPaymentRemnainingExpenses	583832	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P0Y4M13D
	adtx	Stock Issued During Period Values Stock Options Exercised StockIssuedDuringPeriodValuesStockOptionsExercised	423157	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	52524	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	504699	usd
CY2022Q2	adtx	Pursuant Agreement Description PursuantAgreementDescription	Pursuant to the agreement, the Holder has agreed to exercise in cash 8,970,947 of its Series C Warrants at a reduced exercise price of $0.15 per Share (reduced from $1.15 per share), for gross proceeds to the Company of approximately $1.35 million. As an inducement to such exercise, the Company has agreed to reduce the exercise price of the Holder’s remaining Series C Warrants to purchase up to 2,457,623 Shares from $1.15 to $0.2479 per share, which will be non-exercisable for a period of six months following the closing date. The modification of this exercise price resulted in an increase of $344,158 to the fair value of the Series C Warrants. This modification was an inducement on the transaction and as such was recoded to equity resulting in no net change to additional paid in capital. In addition, the Company issued to the Holder a new warrant to purchase up to 20,399,517 shares of the Company’s common stock at an exercise price of $0.2479 per share, which will be non-exercisable for a period of six months following issuance date and have a term of five and one-half years.
CY2022Q2	adtx	Vesting Expense VestingExpense	687375	usd
	adtx	Vesting Expense VestingExpense	0	usd
	adtx	Other Research And Development OtherResearchAndDevelopment	183600	usd
	us-gaap	Other Expenses OtherExpenses	861631	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P0Y9M7D
	adtx	Total Granted TotalGranted	582200	shares
CY2022Q2	adtx	Shares Issued1 SharesIssued1	425375	shares
CY2022Q2	adtx	Shares Issued1 sharesIssued1	425375	shares
	adtx	Preferred Stock Votes PreferredStockVotes	250000000	shares
	adtx	Consideration Cash ConsiderationCash	20000	usd
CY2022Q2	adtx	Principal Amount PrincipalAmount	1477778	usd
CY2022Q2	adtx	Senior Secured Promissory Notes Percentage SeniorSecuredPromissoryNotesPercentage	0.10	pure
CY2022Q2	adtx	Gross Proceeds1 GrossProceeds1	1330000	usd
CY2022Q2	us-gaap	Shares Issued SharesIssued	1477778	shares
CY2022Q2	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	6275065	shares
	adtx	Warrants Exercisable Description WarrantsExercisableDescription	The August 2022 Notes have a maturity date of twelve (12) months from the date of issuance and are convertible at the option of the Investor at any time prior to maturity in shares of Common Stock (the "Conversion Shares") at an initial conversion price of $0.2355 per share, subject to adjustment under certain circumstances. The August 2022 Warrants are exercisable for a period of five (5) years from period commencing on the Commencement Date (as defined therein) and ending on 5:00 p.m. eastern standard time on the date that is five (5) years after the date of issuance, at an exercise price of $0.2355, subject to adjustment provided therein (including cashless exercise).
	adtx	Net Proceeds1 NetProceeds1	1244000	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
	us-gaap	Revenues Revenues		usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021Q2	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2022Q1	adtx	Stock Issued During Period Value Issuance Of Shares For Vested Restricted Stock Units StockIssuedDuringPeriodValueIssuanceOfSharesForVestedRestrictedStockUnits		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	adtx	Note Receivables And Accrued Interest NoteReceivablesAndAccruedInterest		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Interest Expense InterestExpense		usd
	adtx	Lease Liability Recognized From Right Of Use Assets LeaseLiabilityRecognizedFromRightOfUseAssets		usd
	adtx	Original Issuance Discount On Notes Payable OriginalIssuanceDiscountOnNotesPayable		usd
	adtx	Debt Discount From Warrants Issued With Convertible Note Payable DebtDiscountFromWarrantsIssuedWithConvertibleNotePayable		usd
	adtx	Debt Discount From Warrant Consideration For Convertible Debt Offering Costs DebtDiscountFromWarrantConsiderationForConvertibleDebtOfferingCosts		usd
	adtx	Liability Recognized For Financed Assets LiabilityRecognizedForFinancedAssets		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001726711
CY2021Q2	us-gaap	Revenues Revenues		usd

Files In Submission

Name	View Source	Status
0001213900-22-048035-index-headers.html	Edgar Link	pending
0001213900-22-048035-index.html	Edgar Link	pending
0001213900-22-048035.txt	Edgar Link	pending
0001213900-22-048035-xbrl.zip	Edgar Link	pending
adtx-20220630.xsd	Edgar Link	pending
f10q0622ex31-1_aditxtinc.htm	Edgar Link	pending
f10q0622ex31-2_aditxtinc.htm	Edgar Link	pending
f10q0622ex32-1_aditxtinc.htm	Edgar Link	pending
f10q0622_aditxtinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
adtx-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
adtx-20220630_lab.xml	Edgar Link	unprocessable
adtx-20220630_pre.xml	Edgar Link	unprocessable
f10q0622_aditxtinc_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
adtx-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ADTX
Aditxt, Inc. Stock $adtx

2022 Q3 Form 10-Q Financial Statement

#000121390022048035 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX Aditxt, Inc. Stock $adtx

2022 Q3 Form 10-Q Financial Statement

#000121390022048035 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX
Aditxt, Inc. Stock $adtx